Biomarkers for acute myeloid leukemia (AML) – lessons from IL-2 immunotherapy with HDC
Allogeneic transplant for older AML patients - who, when and how
Oncogenic mutational networks in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS)
Do gene mutations impact clinical outcome in elderly acute myeloid leukemia (AML) patients?
Managing transplant ineligible AML patients